Notification of transactions on the Issuer’s shares
09.04.2026
See also
KNF has approved the Syn2bio prospectus. The debut on the WSE is planned for April
- Corporate news
- Investor relations
Extraordinary Shareholders’ Meeting on 19 May 2026
- Corporate news
- Investor relations
Synektik plans to devide. It is spinning off the cardiotracer research project into a new company which will also be listed on the WSE
- Corporate news
- Investor relations